Blood tests aim to find the right antidepressant dose for teens
NCT ID NCT07478796
Summary
This study aims to find better, more personalized doses of three common antidepressants (fluoxetine, sertraline, and escitalopram) for teenagers and young adults with depression. Researchers will use blood tests to measure drug levels and see how they relate to symptom improvement and side effects. The goal is to help doctors prescribe the most effective and safest dose for each individual patient.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION - MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Szpital Kliniczny im. Karola Jonschera UMP (Poznan University of Medical Sciences)
RECRUITINGPoznan, Greater Poland Voivodeship, 60-572, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.